Lv3
370 积分 2025-07-26 加入
The world apheresis association registry, 2023 update
1个月前
已完结
Geriatric perspective: how to assess fitness for chemotherapy in acute myeloid leukemia
1个月前
已完结
Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia
1个月前
已完结
Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia
1个月前
已完结
Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high‐risk myelodysplastic syndrome:
1个月前
已完结
Results of Intensive Chemotherapy in 998 Patients Aged 65 Years or Older with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome - Predictive Prognostic Models for Outcome
1个月前
已关闭
Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia
1个月前
已完结
Venetoclax and decitabine vs intensive chemotherapy as induction for young patients with newly diagnosed AML
3个月前
已完结
A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer
4个月前
已完结
A Generative Foundation Model for Scalable Cytology Image Synthesis in AI-Powered Diagnostics
4个月前
已完结
皖公网安备34019202002308
